Session Type
Meeting
Search Results for substance use
Abstract Number: 131
SHM Converge 2023
Background: Management of heart failure (HF) patients revolves around optimization of guideline directed medical therapy (GDMT) and routine monitoring. Substance use plays a major role as the etiology of HF, especially in a low socioeconomic area with ethnic and racial minority patients. The aim of this study is to find the correlation of alcohol, tobacco […]
Abstract Number: 154
SHM Converge 2023
Background: Over the last few years, the USA has seen a sharp increase in the incidence and prevalence of substance use disorder (SUD) and related acute illnesses. The clinical course of many hospitalized patients is impacted by their diagnosis of SUD. At our institution, we put in place an inpatient addiction service where a physician […]
Abstract Number: 193
SHM Converge 2023
Background: Adolescent e-cigarette use was declared as an epidemic by the U.S. Surgeon general in 2018 and has severe health consequences, including e-cigarette, or vaping, product use-associated lung injury (EVALI). It is known that e-cigarette use is associated with mental health disorders and psychosocial stressors; however, there is a knowledge gap in characterizing psychosocial stressors […]
Abstract Number: 194
SHM Converge 2021
Background: Patients with Substance Use Disorder (SUD) are a nationwide concern. They have significant morbidity, mortality & for several reasons, such as comorbid psychiatric conditions, medication noncompliance, low income or poor access to healthcare services, have an increased risk of hospital readmissions. Processes aimed at reducing readmission rates in this population are important for improving […]
Abstract Number: 255
Hospital Medicine 2020, Virtual Competition
Background: Inpatient addiction consultant services are an innovative and proliferating tool used to confront the opioid epidemic. As healthcare systems seek to address gaps in care for patients with substance use disorder (SUD), the inpatient setting is increasingly understood as a unique opportunity for counseling, referral for treatment, and initiation of medication assistance treatment (MAT) […]
Abstract Number: 398
SHM Converge 2024
Background: Approximately 12% of hospitalizations are related to substance use disorder (SUD), an estimated 20% of hospitalized patients may have SUD, and patients with SUDs are nearly twice as likely to be readmitted. Pharmacotherapies for SUD are underutilized in hospitals, especially in Texas, due to lack of training, structures, and organizational cultures to support evidence-based […]
Abstract Number: 405
SHM Converge 2024
Background: Between 5-30% of hospitalized patients screen positive for unhealthy alcohol use (UAU), and roughly 10-15% of patients have alcohol use disorder (AUD). Brief counseling and medications for AUD are shown to reduce alcohol consumption yet are underutilized in hospitals: over 90% of patients nationally are not screened and treated for UAU. Purpose: To increase […]
Abstract Number: 460
Hospital Medicine 2020, Virtual Competition
Background: Hospitalization provides an opportunity to provide patients who use tobacco with evidence-based treatment for cessation, including nicotine replacement therapy, motivational interviewing, and pharmacotherapy. However, this benefit is often lost without appropriate transitions in care to outpatient cessation resources. We have found that inpatient tobacco cessation interventions at our 600-bed urban academic medical center do […]
Abstract Number: F18
SHM Converge 2022
Background: In utero opioid exposure can result in neonatal abstinence syndrome (NAS). NAS is a serious condition characterized by central nervous system hyperirritability and autonomic nervous system and gastrointestinal tract dysfunction. Newborns with NAS may require pharmacological management, have increased hospital costs, and have a prolonged hospital length of stay (LOS). NAS incidence has increased […]
Oral Presentations
Abstract Number: OP12
SHM Converge 2022
Background: Previous studies have documented discriminatory refusals from post-acute care facilities related to opioid use disorder or opioid agonist therapy, however the impact of inability to secure skilled nursing facility (SNF) placement for patients with any substance use disorder (SUD) has not been fully explored. The objective of this study is to measure the odds […]